AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « influence »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
infliximab < influence < influenced  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 43.
[0-20] [0 - 20][0 - 43][20-40]
Ident.Authors (with country if any)Title
000009 (2008) Misato Hashizume [Japon] ; Masahiko Mihara [Japon]Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling
000021 (2010) Nicolas Frey [Suisse] ; Susan Grange [Suisse] ; Thasia Woodworth [Royaume-Uni]Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis
000052 (2009) Miho Suzuki [Japon] ; Misato Hashizume [Japon] ; Hiroto Yoshida [Japon] ; Masahiko Mihara [Japon]Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule
000179 (2009) Masahiko Mihara [Japon] ; Yoshiyuki Ohsugi [Japon] ; Tadamitsu KishimotoEvidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody
000186 (2010) Christoph Strehblow [Autriche] ; Guenther Haberhauer [Autriche] ; Peter Fasching [Autriche]Comparison of different biologic agents in patients with rheumatoid arthritis after failure of the first biologic therapy
000190 (2008) N. Leuchten [Allemagne] ; M. Aringer [Allemagne]Rheumatoide Arthritis/chronische Polyarthritis heute
000234 (2012) G. Lippi [Italie] ; G. Targher [Italie]Optimal therapy for reduction of lipoprotein(a)
000278 (2013) Frédéric Perros [France] ; Marc Humbert [France] ; Sylvia Cohen-Kaminsky [France]Hypertension artérielle pulmonaire
000282 (2010) Gert Hein [Allemagne] ; Thorsten Eidner [Allemagne] ; Peter Oelzner [Allemagne] ; Michael Rose [Allemagne] ; Alexander Wilke [Allemagne] ; Gunter Wolf [Allemagne] ; Sybille Franke [Allemagne]Influence of Rituximab on markers of bone remodeling in patients with rheumatoid arthritis: a prospective open-label pilot study
000284 (2012) Usama Elewa [Espagne] ; Maria Dolores Sanchez-Ni O [Espagne] ; Catalina Martin-Cleary [Espagne] ; Beatriz Fernandez-Fernandez [Espagne] ; Jesus Egido [Espagne] ; Alberto Ortiz [Espagne]Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled
000394 (2012) M. Wahle [Allemagne]Anämie bei Patienten mit rheumatoider Arthritis
000421 (2013) P. N. Morcos [États-Unis] ; S. A. Moreira [États-Unis] ; B. J. Brennan [États-Unis] ; S. Blotner [États-Unis] ; N. S. Shulman [États-Unis] ; P. F. Smith [États-Unis]Influence of chronic hepatitis C infection on cytochrome P450 3a4 activity using midazolam as an in vivo probe substrate
000450 (2013) T. Popkova [Russie] ; D. Novikova [Russie] ; E. Udachkina [Russie] ; E. Panasuk [Russie] ; A. Avdeeva [Russie] ; E. Alexandrova [Russie] ; A. Novikov [Russie] ; A. Volkov [Russie] ; E. Nasonov [Russie]AB0578 Tocilizumab influence on the serum lipid profiles and rapid progression of intima media-thickness in patients with rheumatoid arthritis
000512 (2010) Aharon Kessel [Israël] ; Regina Peri [Israël] ; Tharwat Haj [Israël] ; Ayelet Snir [Israël] ; Gleb Slobodin [Israël] ; Edmond Sabo [Israël] ; Itzhak Rosner [Israël] ; Yehuda Shoenfeld [Israël] ; Elias Toubi [Israël]IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients
000538 (2013) S. Lindblad ; L. Stawiarz [Suède]FRI0205 Gender and previous treatment influence outcomes from abatacept in a 5-year rheumatoid arthritis cohort
000782 (2013) L. Gossec [France]SP0062 What is the Influence of the Patient Component in RA Remission Criteria?
000862 (2011) Shunichi Shiozawa [Japon] ; Ken Tsumiyama [Japon] ; Kohsuke Yoshida [Japon] ; Akira Hashiramoto [Japon]Pathogenesis of Joint Destruction in Rheumatoid Arthritis
000925 (2012) P. A. Laires [Portugal] ; F. Exposto [Portugal] ; R. Mesquita [Portugal] ; A. P. Martins [Portugal] ; L. Cunha-Miranda [Portugal] ; J. E. Fonseca [Portugal]Patients’ access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries
000A48 (2010) Maria José Santos [Portugal] ; Diana Fernandes [Portugal] ; Susana Capela [Portugal] ; Jose Canas Da Silva [Portugal] ; João Eurico Fonseca [Portugal]Interleukin-6 promoter polymorphism −174 G/C is associated with nephritis in Portuguese Caucasian systemic lupus erythematosus patients
000A53 (2010) Hiroto Yoshida [Japon] ; Misato Hashizume [Japon] ; Masahiko Mihara [Japon]IL-6 blockade preferentially inhibits Th17 differentiation in collagen-induced arthritis
000A76 (2011) R. L Pez-Mejías [Espagne] ; M. García-Bermúdez [Espagne] ; C. González-Juanatey [Espagne] ; S. Casta Eda [Espagne] ; J. A. Miranda-Filloy [Espagne] ; C. G Mez-Vaquero [Espagne] ; B. Fernández-Gutiérrez [Espagne] ; A. Balsa [Espagne] ; D. Pascual-Salcedo [Espagne] ; R. Blanco [Espagne] ; I. González-Álvaro [Espagne] ; J. Llorca [Espagne] ; J. Martín [Espagne] ; M. A. González-Gay [Espagne]Lack of association of IL6R rs2228145 and IL6ST/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "influence" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "influence" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    influence
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021